Srinath Palakurthi

Srinath Palakurthi

Professor of Pharmaceutical Sciences

Texas A&M Irma Lerma Rangel College of Pharmacy
1010 W. Ave. B
Kingsville, Texas   78363

Phone: 361.221.0748
Fax: 361.221.0793

Education and Training

Indian Institute of Chemical Technology, India
PhD in Pharmaceutics, 2000

Dr. H.S. Gour University, India
MPharm, Pharmaceutics, 1993

Kakatiya University, India
Bachelor of Science Pharmaceutical Sciences, 1990

Teaching Interests

  • Physicochemical and biopharmaceutical principles
  • Nanoparticles

Research Interests

  • Novel polymers for gene therapy
  • Polymer-based nanoparticles for targeted delivery of chemotherapeutics for the treatment of ovarian cancer
  • Mucosal delivery of chemotherapeutics and antigens
  • Cellular trafficking of nanoconstructs. 

Selected Publications

  • Palakurthi, S., Wilson, J., McQuarrie, S.A., et al. (2008) “Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells.” In vivo. 22(3):321-326.
  • Kumar, A., Yellepeddi, V., Guan, X., Davies, G., Palakurthi, S. (2008) “Enhanced gene transfection efficiency of ornithine-conjugated PAMAM dendrimers.” Journal of Pharmaceutical Science.
  • Pisal, D., Yellepeddi, V., Kumar, A., Palakurthi, S. (2008) “Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.” Drug Delivery (in press).
  • Pisal, D., Yellepeddi, V., Kumar, A., Guan, X., Kaushik, R., Hildreth, M., Palakurthi, S. (2008) “Permeability of surface modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.”International Journal of Pharmaceutics. 350(1-2), 113-121.
  • Palakurthi, S.,  McQuarrie, S.A. and Suresh M.R. (2007) “Radiopharmaceutical Screening of 14C-polyamines in the AT3B-1 Rat prostate Tumor Model: A Search for a New PET Prostate Imaging Agent.” In vivo. 21, 823-828. 

National Service & Recognition

  • Speaker at the 2nd World Conference on Magic Bullets (Ehrlich II) in Nurnberg, Germany
  • Speaker at the 8th International Conference of Anticancer Research in Kos, Greece
  • Reviewer for the Department of Defense (DOD)-Prostate Cancer Research Program (DOD-PCRP FY08)
  • Reviewer for the DOD-Peer Reviewed Medical Research Program (DOD-PRMRP FY08)